The following is a summary of “Intrathecal interleukin-6 levels are associated with progressive disease and clinical severity in multiple sclerosis,” published in the April 2025 issue of BMC Neurology by […]
The post Intrathecal Interleukin-6 Reflects Disease Progression and Severity in Multiple Sclerosis first appeared on Blackandmed .